Preliminary studies are also investigating the role of expression levels of the marker of cellular senescence p16INK4a, as well as biomarkers of sarcopenia such as myostatin and insulin-like growth factor levels [32,47,48]. The gene discussed is CDKN2A; the disease is sarcopenia.